Phagenesis

Contact
phagenesis.com
+44 161 820 4525

Phagenesis Ltd

Enterprise House
M15 6SE Manchester
United Kingdom
+44 161 820 4525
phagenesis.com
Contact
Profile News
Contact

About Phagenesis

We have developed the world first clinically proven treatment for dysphagia following neurological conditions. The treatment, Phagenyx, is the result of more than 20 years development by Professor Shaheen Hamdy and his team at the University of Manchester. Phagenyx is available in the Germany, Austria, the UK, Ireland and other european countries.

Read more about Phagenesis
Facts about Phagenesis
  • Focus : Manufacturer
  • Employees: 11-50
  • Industry : Pharma

News about Phagenesis

Phagenesis

26-Oct-2012 | research and development

Phagenesis Launches First Treatment for Acute Dysphagia

Phagenesis launches the world's first approved treatment for acute dysphagia following stroke. The Phagenyx™ system delivers calibrated electrical stimulus ...

Read news
Phagenesis

24-May-2012 | research and development

Phagenesis Wins c. £1 million Translation Award by Wellcome Trust to Expand Dysphagia Treatment

Phagenesis Ltd has been awarded c. £1 million from the Wellcome Trust to extend the scope of its dysphagia treatment device, from hospitals into the ...

Read news
Phagenesis

06-Oct-2011 | business & finance

Phagenesis closes €7million Series B financing round

Phagenesis Ltd announced that it has closed a €7 million Series B funding round designed to accelerate the company’s development plans. The investment is ...

Read news
Phagenesis

12-Jul-2010 | people

Phagenesis appoints Chairman and CEO

Phagenesis Limited has appointed Henry Hyde-Thomson as Chairman and Daniel Green as Chief Executive Officer. They will lead Phagenesis in the development ...

Read news
Show more news about Phagenesis

Here you will find Phagenesis Ltd